D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 142 Citations 71,014 706 World Ranking 45 National Ranking 32
Medicine D-index 148 Citations 82,218 858 World Ranking 458 National Ranking 278

Research.com Recognitions

Awards & Achievements

2012 - Member of the National Academy of Medicine (NAM)

2008 - Fellow of the American Association for the Advancement of Science (AAAS)

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Immune system

His primary areas of investigation include Immunology, Transplantation, Graft-versus-host disease, Internal medicine and Immune system. His studies in Immunology integrate themes in fields like Cytotoxic T cell and Stem cell. His Cytotoxic T cell research is multidisciplinary, relying on both T cell and Molecular biology.

His Transplantation research integrates issues from Total body irradiation, Histocompatibility, Bone marrow, Transplantation Conditioning and Fludarabine. His Graft-versus-host disease research incorporates themes from Blockade, Hematopoietic stem cell transplantation, Cytokine and Pharmacology. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Umbilical cord and Surgery.

His most cited work include:

  • Microbial translocation is a cause of systemic immune activation in chronic HIV infection (2742 citations)
  • Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. (1213 citations)
  • Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity (1206 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Immunology, Transplantation, Graft-versus-host disease, T cell and Internal medicine. His Immunology research includes themes of Hematopoietic stem cell transplantation and Stem cell. His biological study deals with issues like Leukemia, which deal with fields such as Myeloid leukemia.

Bruce R. Blazar has included themes like Germinal center and Major histocompatibility complex in his Graft-versus-host disease study. His T cell study combines topics in areas such as Cytotoxic T cell, Cancer research, Antigen and Cell biology. The various areas that he examines in his Internal medicine study include Gastroenterology, Endocrinology, Surgery and Oncology.

He most often published in these fields:

  • Immunology (57.68%)
  • Transplantation (28.24%)
  • Graft-versus-host disease (25.74%)

What were the highlights of his more recent work (between 2017-2021)?

  • Graft-versus-host disease (25.74%)
  • Transplantation (28.24%)
  • Immunology (57.68%)

In recent papers he was focusing on the following fields of study:

Graft-versus-host disease, Transplantation, Immunology, T cell and Cancer research are his primary areas of study. His Graft-versus-host disease research focuses on Gastroenterology and how it connects with Umbilical cord. Bruce R. Blazar has researched Transplantation in several fields, including Haematopoiesis, Stem cell, Clinical trial, Adoptive cell transfer and CD80.

He regularly links together related areas like Hematopoietic stem cell transplantation in his Immunology studies. His T cell study incorporates themes from Cytotoxic T cell, CD8, Cytokine and Cell biology. His research in Cancer research intersects with topics in In vivo, Leukemia, Antigen and Immunotherapy.

Between 2017 and 2021, his most popular works were:

  • Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade (186 citations)
  • Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism. (160 citations)
  • First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation (141 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Immune system

Bruce R. Blazar mainly investigates T cell, Cancer research, Cell biology, Immunology and Immune system. The study incorporates disciplines such as CD8, Priming, Innate immune system, Autoimmunity and Immunotherapy in addition to T cell. His Cancer research study integrates concerns from other disciplines, such as Cytotoxic T cell, Receptor, In vivo and Antigen.

His Cell biology research integrates issues from Regulatory T cell, Cell and FOXP3. His Immunology research is multidisciplinary, incorporating elements of Graft-versus-host disease, Hematopoietic stem cell transplantation and Transplantation. Bruce R. Blazar has included themes like Tumor progression, Stem cell, Cytokine and Myeloid-derived Suppressor Cell in his Immune system study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Jason M. Brenchley;David A. Price;Timothy W. Schacker;Tedi E. Asher.
Nature Medicine (2006)

3468 Citations

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

John E. Wagner;Juliet N. Barker;Todd E. DeFor;K. Scott Baker.
Blood (2002)

1455 Citations

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.

Jeffrey S. Miller;Yvette Soignier;Angela Panoskaltsis-Mortari;Sarah A. McNearney.
Blood (2005)

1407 Citations

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

Kaori Sakuishi;Lionel Apetoh;Jenna M. Sullivan;Bruce R. Blazar.
Journal of Experimental Medicine (2010)

1316 Citations

The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.

Patricia A. Taylor;Christopher J. Lees;Bruce R. Blazar.
Blood (2002)

1244 Citations

Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy

Juliet N. Barker;Daniel J. Weisdorf;Todd E. DeFor;Bruce R. Blazar.
Blood (2005)

1023 Citations

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.

Claudio G. Brunstein;Jeffrey S. Miller;Qing Cao;David H. McKenna.
Blood (2011)

956 Citations

Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers

Ricardo Spielberger;Patrick Stiff;William Bensinger;Teresa Gentile.
The New England Journal of Medicine (2004)

917 Citations

IL-2 Receptor β-Dependent STAT5 Activation Is Required for the Development of Foxp3+ Regulatory T Cells

Matthew A. Burchill;Jianying Yang;Christine Vogtenhuber;Bruce R. Blazar.
Journal of Immunology (2007)

852 Citations

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

Madhav D. Sharma;Babak Baban;Phillip Chandler;De Yan Hou.
Journal of Clinical Investigation (2007)

808 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Bruce R. Blazar

Daniel J. Weisdorf

Daniel J. Weisdorf

University of Minnesota

Publications: 188

Paul J. Martin

Paul J. Martin

Fred Hutchinson Cancer Research Center

Publications: 144

Marcel R.M. van den Brink

Marcel R.M. van den Brink

Memorial Sloan Kettering Cancer Center

Publications: 142

John E. Wagner

John E. Wagner

University of Minnesota

Publications: 136

Franco Locatelli

Franco Locatelli

Bambino Gesù Children's Hospital

Publications: 123

Claudio Anasetti

Claudio Anasetti

Fred Hutchinson Cancer Research Center

Publications: 122

Arnon Nagler

Arnon Nagler

Sheba Medical Center

Publications: 120

Richard E. Champlin

Richard E. Champlin

The University of Texas MD Anderson Cancer Center

Publications: 119

Mohamad Mohty

Mohamad Mohty

Université Paris Cité

Publications: 115

Geoffrey R. Hill

Geoffrey R. Hill

Fred Hutchinson Cancer Research Center

Publications: 114

Xiao-Jun Huang

Xiao-Jun Huang

Peking University

Publications: 113

Sergio Giralt

Sergio Giralt

Memorial Sloan Kettering Cancer Center

Publications: 111

James L.M. Ferrara

James L.M. Ferrara

Icahn School of Medicine at Mount Sinai

Publications: 110

Joseph H. Antin

Joseph H. Antin

Harvard University

Publications: 110

Elizabeth J. Shpall

Elizabeth J. Shpall

The University of Texas MD Anderson Cancer Center

Publications: 108

Pavan Reddy

Pavan Reddy

University of Michigan–Ann Arbor

Publications: 106

Trending Scientists

Paul Suetens

Paul Suetens

KU Leuven

Chinlon Lin

Chinlon Lin

Nokia (United States)

Sergey Shleev

Sergey Shleev

Malmö University

Jin Suk Chung

Jin Suk Chung

University of Ulsan

Guang Ye

Guang Ye

Delft University of Technology

Jürgen H. Werner

Jürgen H. Werner

University of Stuttgart

Dirk Ponge

Dirk Ponge

Max Planck Society

Xiaobo Chen

Xiaobo Chen

University of Missouri–Kansas City

Wilfried Wackernagel

Wilfried Wackernagel

Carl von Ossietzky University of Oldenburg

Alan G. Hinnebusch

Alan G. Hinnebusch

National Institutes of Health

Gourisankar Ghosh

Gourisankar Ghosh

University of California, San Diego

Navindra P. Seeram

Navindra P. Seeram

University of Rhode Island

Fen-Biao Gao

Fen-Biao Gao

University of Massachusetts Medical School

Garry T. Cole

Garry T. Cole

The University of Texas at San Antonio

Soheyl Noachtar

Soheyl Noachtar

Ludwig-Maximilians-Universität München

Neil W. Mulligan

Neil W. Mulligan

University of North Carolina at Chapel Hill

Something went wrong. Please try again later.